Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Effect of lipid extracts of Nigella sativa L. seeds on the liver ATP reduction and alpha-glucosidase inhibition.

Sobhi W, Stevigny C, Duez P, Calderon BB, Atmani D, Benboubetra M.

Pak J Pharm Sci. 2016 Jan;29(1):111-7.

PMID:
26826824
2.

Thymoquinone strongly inhibits fMLF-induced neutrophil functions and exhibits anti-inflammatory properties in vivo.

Boudiaf K, Hurtado-Nedelec M, Belambri SA, Marie JC, Derradji Y, Benboubetra M, El-Benna J, Dang PM.

Biochem Pharmacol. 2016 Mar 15;104:62-73. doi: 10.1016/j.bcp.2016.01.006. Epub 2016 Jan 13.

PMID:
26774451
3.

Kinetic study on the inhibition of xanthine oxidase by extracts from two selected Algerian plants traditionally used for the treatment of inflammatory diseases.

Berboucha M, Ayouni K, Atmani D, Atmani D, Benboubetra M.

J Med Food. 2010 Aug;13(4):896-904. doi: 10.1089/jmf.2009.0164.

PMID:
20553185
4.

Early inhibition of EGFR signaling prevents diabetes-induced up-regulation of multiple gene pathways in the mesenteric vasculature.

Benter IF, Benboubetra M, Hollins AJ, Yousif MH, Canatan H, Akhtar S.

Vascul Pharmacol. 2009 Oct;51(4):236-45. doi: 10.1016/j.vph.2009.06.008. Epub 2009 Jul 2.

PMID:
19577003
5.

Global upregulation of gene expression associated with renal dysfunction in DOCA-salt-induced hypertensive rats occurs via signaling cascades involving epidermal growth factor receptor: a microarray analysis.

Benter IF, Canatan H, Benboubetra M, Yousif MH, Akhtar S.

Vascul Pharmacol. 2009 Aug-Sep;51(2-3):101-9. doi: 10.1016/j.vph.2009.04.004. Epub 2009 May 4.

PMID:
19410658
6.

Purification and partial characterisation of camel milk xanthine oxidoreductase.

Baghiani A, Harrison R, Benboubetra M.

Arch Physiol Biochem. 2003 Dec;111(5):407-14.

PMID:
16026028
7.
8.

Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies.

Khan A, Benboubetra M, Sayyed PZ, Ng KW, Fox S, Beck G, Benter IF, Akhtar S.

J Drug Target. 2004 Jul;12(6):393-404. Erratum in: J Drug Target. 2004;12(7):473.

PMID:
15545089
9.

Physicochemical and kinetic properties of purified sheep's milk xanthine oxidoreductase.

Benboubetra M, Baghiani A, Atmani D, Harrison R.

J Dairy Sci. 2004 Jun;87(6):1580-4.

10.

Prion protein protects against DNA damage induced by paraquat in cultured cells.

Senator A, Rachidi W, Lehmann S, Favier A, Benboubetra M.

Free Radic Biol Med. 2004 Oct 15;37(8):1224-30.

PMID:
15451062
11.
12.

Evaluation of generation 2 and 3 poly(propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor.

Hollins AJ, Benboubetra M, Omidi Y, Zinselmeyer BH, Schatzlein AG, Uchegbu IF, Akhtar S.

Pharm Res. 2004 Mar;21(3):458-66.

PMID:
15070097
13.

Goats' milk xanthine oxidoreductase is grossly deficient in molybdenum.

Atmani D, Benboubetra M, Harrison R.

J Dairy Res. 2004 Feb;71(1):7-13.

PMID:
15068060
14.
15.

Prion infection impairs copper binding of cultured cells.

Rachidi W, Mangé A, Senator A, Guiraud P, Riondel J, Benboubetra M, Favier A, Lehmann S.

J Biol Chem. 2003 Apr 25;278(17):14595-8. Epub 2003 Mar 10.

16.

Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome.

Bowes T, Wagner ER, Boffey J, Nicholl D, Cochrane L, Benboubetra M, Conner J, Furukawa K, Furukawa K, Willison HJ.

Infect Immun. 2002 Sep;70(9):5008-18.

17.

Xanthine oxidoreductase in human mammary epithelial cells: activation in response to inflammatory cytokines.

Page S, Powell D, Benboubetra M, Stevens CR, Blake DR, Selase F, Wolstenholme AJ, Harrison R.

Biochim Biophys Acta. 1998 Jul 23;1381(2):191-202.

PMID:
9685639
18.

A reappraisal of xanthine dehydrogenase and oxidase in hypoxic reperfusion injury: the role of NADH as an electron donor.

Zhang Z, Blake DR, Stevens CR, Kanczler JM, Winyard PG, Symons MC, Benboubetra M, Harrison R.

Free Radic Res. 1998 Feb;28(2):151-64.

PMID:
9645392
19.

Xanthine oxidoreductase is asymmetrically localised on the outer surface of human endothelial and epithelial cells in culture.

Rouquette M, Page S, Bryant R, Benboubetra M, Stevens CR, Blake DR, Whish WD, Harrison R, Tosh D.

FEBS Lett. 1998 Apr 24;426(3):397-401.

20.

Xanthine oxidase: four roles for the enzyme in rheumatoid pathology.

Blake DR, Stevens CR, Sahinoglu T, Ellis G, Gaffney K, Edmonds S, Benboubetra M, Harrison R, Jawed S, Kanczler J, Millar TM, Winyard PG, Zhang Z.

Biochem Soc Trans. 1997 Aug;25(3):812-6. Review. No abstract available.

PMID:
9388551
21.

Circulating anti-(xanthine oxidoreductase) antibodies in healthy human adults.

Benboubetra M, Gleeson A, Harris CP, Khan J, Arrar L, Brennand D, Reid J, Reckless JD, Harrison R.

Eur J Clin Invest. 1997 Jul;27(7):611-9.

PMID:
9263750
22.

Cytokine-induced activation of xanthine oxidase in human mammary epithelial cells.

Page S, Benboubetra M, Blake D, Powell D, Selase F, Stevens C, Wolstenholme A, Harrison R.

Biochem Soc Trans. 1997 Feb;25(1):95S. No abstract available.

PMID:
9056993
23.

Xanthine oxidase activity and subcellular localisation in human mammary epithelial cells.

Powell D, Benboubetra M, Newey S, Harrison R.

Biochem Soc Trans. 1995 Nov;23(4):616S. No abstract available.

PMID:
8654801
24.

Molecular activation-deactivation of xanthine oxidase in human milk.

Brown AM, Benboubetra M, Ellison M, Powell D, Reckless JD, Harrison R.

Biochim Biophys Acta. 1995 Oct 19;1245(2):248-54.

PMID:
7492585
25.

Molecular activity of human milk xanthine oxidase varies with time after parturition.

Brown AM, Benboubetra M, Ellison M, Reckless JD, Harrison R.

Biochem Soc Trans. 1994 Nov;22(4):444S. No abstract available.

PMID:
7698462
26.

Purification and partial characterization of xanthine oxidase from human milk.

Abadeh S, Killacky J, Benboubetra M, Harrison R.

Biochim Biophys Acta. 1992 Jul 21;1117(1):25-32.

PMID:
1627588
27.

Localisation of xanthine oxidase to synovial endothelium.

Stevens CR, Benboubetra M, Harrison R, Sahinoglu T, Smith EC, Blake DR.

Ann Rheum Dis. 1991 Nov;50(11):760-2.

28.

Purification of xanthine oxidase from human milk.

Harrison R, Abadah S, Benboubetra M.

Biochem Soc Trans. 1991 Aug;19(3):332S. No abstract available.

PMID:
1783165
29.

Purification of xanthine oxidase from human milk.

Harrison R, Abadeh S, Benboubetra M.

Adv Exp Med Biol. 1991;309A:335-8. No abstract available.

PMID:
1789237
30.

Human monoclonal antibodies to xanthine oxidase.

Benboubetra M, Ainge N, Harrison R.

Biochem Soc Trans. 1990 Oct;18(5):1008-9. No abstract available.

PMID:
2083633
31.

Anti-xanthine oxidase antibodies and coronary heart disease.

Benboubetra M, Harrison R, Thomas RD.

Biochem Soc Trans. 1990 Oct;18(5):1007-8. No abstract available.

PMID:
2083632
32.

Antibodies to xanthine oxidase: elevated levels in patients with acute myocardial infarction.

Harrison R, Benboubetra M, Bryson S, Thomas RD, Elwood PC.

Cardioscience. 1990 Sep;1(3):183-9.

PMID:
2102807

Supplemental Content

Loading ...
Support Center